Processa Pharmaceuticals, Inc.
PCSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001533743
In the last 90 days, Processa Pharmaceuticals, Inc. insiders filed 5 open-market purchases and 0 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $498.3K in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Processa Pharmaceuticals, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +1 vs. Q2 2023
- Shares held
- 1.39M
- −3.63K (−0.3%) vs. Q2 2023
- Total value
- $349.8K
- −$341.6K (−49.4%) vs. Q2 2023
- New holders
- 4
- 7 more added
- Sold out
- 3
- 4 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PCSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 12 | $498.3K |
| Q1 2026 | 10 | $448.5K |
| Q4 2025 | 10 | $331.0K |
| Q3 2025 | 14 | $341.9K |
| Q2 2025 | 13 | $75.9K |
| Q1 2025 | 9 | $63.2K |
| Q4 2024 | 8 | $87.5K |
| Q3 2024 | 8 | $66.5K |
| Q2 2024 | 9 | $101.0K |
| Q1 2024 | 11 | $251.5K |
| Q4 2023 | 18 | $376.5K |
| Q3 2023 | 20 | $349.8K |
| Q2 2023 | 19 | $691.4K |
| Q1 2023 | 22 | $852.6K |
| Q4 2022 | 18 | $1.28M |
| Q3 2022 | 18 | $2.58M |
| Q2 2022 | 18 | $3.24M |
| Q1 2022 | 18 | $3.22M |
| Q4 2021 | 19 | $6.47M |
| Q3 2021 | 18 | $12.2M |
| Q2 2021 | 18 | $11.2M |
| Q1 2021 | 17 | $12.3M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Processa Pharmaceuticals, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Macroview Investment Management LLC | 12 | $3 | 0.00% | +12 | New |
| JPMorgan Chase & Co | 20 | $5 | 0.00% | +20 | New |
| BlackRock Inc. | 293 | $73 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 707 | $177 | 0.00% | +707 | New |
| Allworth Financial LP | 1,700 | $426 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 3,238 | $810 | 0.00% | +18+0.6% | Added |
| Tower Research Capital LLC (TRC) | 10,094 | $2.52K | 0.00% | +1,298+14.8% | Added |
| Virtu Financial LLC | 11,617 | $3.00K | 0.00% | −15,056−56.4% | Reduced |
| Northern Trust Corp | 15,401 | $3.85K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 19,346 | $4.00K | 0.00% | +19,346 | New |
| Mirador Capital Partners LP | 19,516 | $4.88K | 0.00% | +758+4.0% | Added |
| Millennium Management LLC | 25,930 | $6.61K | 0.00% | −9,263−26.3% | Reduced |
| State Street Corp | 42,786 | $10.9K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 46,382 | $12.0K | 0.00% | +46,231+30,616.6% | Added |
| Renaissance Technologies LLC | 53,900 | $13.0K | 0.00% | +8,500+18.7% | Added |
| Coastal Bridge Advisors, LLC | 52,500 | $13.1K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 152,670 | $38.9K | 0.00% | +83,843+121.8% | Added |
| Citadel Advisors LLC | 166,224 | $42.4K | 0.00% | −116,613−41.2% | Reduced |
| Vanguard Group Inc | 344,425 | $86.2K | 0.00% | −17,254−4.8% | Reduced |
| Walleye Capital LLC | 419,277 | $106.9K | 0.00% | +52,640+14.4% | Added |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −28,108−100.0% | Sold out |
| Verdence Capital Advisors LLC | 0 | $0 | 0.00% | −20,012−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −10,700−100.0% | Sold out |